Begin main content

Reports

We found 5989 result(s)

vedolizumab (Entyvio )

Last Updated: April 2, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vedolizumab
Indications: Ulcerative Colitis

  • Brand Name: Entyvio
  • Manufacturer: Takeda Canada Inc.
  • Project Number: SR0635-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: April 3, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New Indication

budesonide (Jorveza)

Last Updated: April 2, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New

brolucizumab (Beovu)

Last Updated: April 2, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: brolucizumab
Indications: Macular degeneration, age-related

  • Brand Name: Beovu
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0632-000
  • Project Status: Active
  • Submission Type: New

eculizumab (Soliris )

Last Updated: April 2, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: eculizumab
Indications: Myasthenia Gravis (gMG), adults

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada Corp.
  • Project Number: SR0605-000
  • Project Status: Received
  • Submission Type: New Indication